These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26216028)

  • 1. Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy.
    Luo M; Liu H; Hu SJ; Bai FH
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):665-73. PubMed ID: 26216028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.
    Luo M; Guo JY; Cao WK
    World J Gastroenterol; 2015 Nov; 21(41):11815-24. PubMed ID: 26557005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and hepatic encephalopathy.
    Coltart I; Tranah TH; Shawcross DL
    Arch Biochem Biophys; 2013 Aug; 536(2):189-96. PubMed ID: 23583306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets.
    Butterworth RF
    Neurochem Int; 2011 Nov; 59(6):830-6. PubMed ID: 21864609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory.
    Odeh M
    Eur J Clin Invest; 2007 Apr; 37(4):291-304. PubMed ID: 17373965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights into the pathogenesis of hepatic encephalopathy and treatments.
    Sturgeon JP; Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):83-100. PubMed ID: 24236755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammation and ammonia in hepatic encephalopathy.
    Tranah TH; Vijay GK; Ryan JM; Shawcross DL
    Metab Brain Dis; 2013 Mar; 28(1):1-5. PubMed ID: 23224356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.
    Shawcross DL; Shabbir SS; Taylor NJ; Hughes RD
    Hepatology; 2010 Mar; 51(3):1062-9. PubMed ID: 19890967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts.
    Agusti A; Cauli O; Rodrigo R; Llansola M; Hernández-Rabaza V; Felipo V
    Gut; 2011 Nov; 60(11):1572-9. PubMed ID: 21636647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts.
    Cauli O; Rodrigo R; Piedrafita B; Boix J; Felipo V
    Hepatology; 2007 Aug; 46(2):514-9. PubMed ID: 17659565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation.
    Shawcross D; Jalan R
    Cell Mol Life Sci; 2005 Oct; 62(19-20):2295-304. PubMed ID: 16158192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline.
    Jiang W; Desjardins P; Butterworth RF
    J Neurochem; 2009 Apr; 109(2):485-93. PubMed ID: 19220703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure.
    Bernal W; Hall C; Karvellas CJ; Auzinger G; Sizer E; Wendon J
    Hepatology; 2007 Dec; 46(6):1844-52. PubMed ID: 17685471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory strategies for hepatic encephalopathy: preclinical studies.
    Santos RPC; Toscano ECB; Rachid MA
    Arq Neuropsiquiatr; 2023 Jul; 81(7):656-669. PubMed ID: 37487550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic encephalopathy: from pathophysiology to treatment.
    Mas A
    Digestion; 2006; 73 Suppl 1():86-93. PubMed ID: 16498256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical science workshop: targeting the gut-liver-brain axis.
    Patel VC; White H; Støy S; Bajaj JS; Shawcross DL
    Metab Brain Dis; 2016 Dec; 31(6):1327-1337. PubMed ID: 26446022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic encephalopathy].
    Häussinger D
    Praxis (Bern 1994); 2006 Oct; 95(40):1543-9. PubMed ID: 17048412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.